Dechra Pharmaceuticals

World Rank (Jul-30-2023)
2,759
Market Cap (Jul-30-2023)
5.433 Billion USD
World Rank (Dec-25-2022)
3,556
Market Cap (Dec-25-2022)
3.614 Billion USD
World Rank (Jan-07-2022)
2,623
Market Cap (Jan-07-2022)
6.583 Billion USD
World Rank (Jan-01-2021)
2,881
Market Cap (Jan-01-2021)
5.102 Billion USD
Company Rank in Country in 2023
Company rank in UK in July-2023 is 98
Annual Revenue in USD
716 Million USD
Annual Net Income in USD
65 Million USD
Total Assets in USD
1,430 Million USD
Total Liabilities in USD
684 Million USD
Annual Results for Year ending in
Jun-2022 month
Headquarters Country
UK
Company Business
Healthcare
Pharmaceutical
HealthCare Products
Animal Healthcare Companies
Animal Health Medicine
Stock Category
FTSE 100
Stock Exchange
Frankfurt
LSE
Company Rank in Country in 2022
Company Rank in UK in 2022 is 111
Rank in Country (Jan-2021)
Company Rank in UK in 2021 is 122
Rank in Country (Jan-2020)
Rank in UK in 2020 is 142
Number of Employees
2,400
Employee Count as on Date
As on 2023
ISIN Code:
GB0009633180
Yahoo
Yahoo @ LSE
Company Website:
DECHRA PHARMACEUTICALS
About Company Business:

Dechra Pharmaceuticals is a specialist Veterinary Pharmaceuticals and related products business. It expertise is in the development, manufacture and sales and marketing of high quality products exclusively for veterinarians worldwide. The headquarters is in UK.

Facts About Company

Dechra Pharmaceuticals annual revenue was 681 million GBP and annual net income was 58 million GBP generated for period year ending Jun-2022.

Dechra Pharmaceuticals annual revenue was 608 million GBP and annual net income was 55 million GBP generated for period year ending Jun-2021.

As on 2023, Dechra Pharmaceuticals had 2400 employees.

Founded Year
1997
Annual Results Summary:

DECHRA PHARMACEUTICALS  - Annual Results - Revenue and Net Income - in Million GBP:

Year -Ending Revenue Operating Income Net Income
Jun-2022 681 170 58 
Jun-2021 608  87 55
Jun-2020 515 58 33
Jun-2019 481 45 30
Balance Sheet Summary

Total Assets as on Jun-2022 was 1,293  Million GBP.

Total Liabilities as on Jun-2022 was 626 Million GBP.

Total Equity as on Jun-2022 was 666 Million GBP.

Share it on Social Media